Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on: January 25,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on:January 25,2024

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Updated on: January 04,2024

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Updated on:January 04,2024

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un

Updated on: May 05,2024

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un

Updated on:May 05,2024

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on: January 10,2024

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on:January 10,2024

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp

Updated on: January 08,2024

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp

Updated on:January 08,2024

After breast cancer: 5 changes you can make to stay healthy

by Marina Reeves, Caroline Olivia Terranova, Kelly D'cunha and Sandra Hayes,The ConversationCredit: PexelsEvery year, more than20,000 Australians—mostly women—are diagnosed with breast

Updated on: January 02,2024

After breast cancer: 5 changes you can make to stay healthy

by Marina Reeves, Caroline Olivia Terranova, Kelly D'cunha and Sandra Hayes,The ConversationCredit: PexelsEvery year, more than20,000 Australians—mostly women—are diagnosed with breast

Updated on:January 02,2024

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I

Updated on: September 06,2024

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I

Updated on:September 06,2024

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on: January 30,2024

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on:January 30,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on: February 20,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on:February 20,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

Modification makes immunotherapy for blood cancer even more effective

Updated on: June 14,2025

Modification makes immunotherapy for blood cancer even more effective

Updated on:June 14,2025

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on: January 25,2024

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on:January 25,2024